SCHEMBL28093533

SCHEMBL28093533

CC(C)(C)SN=Cc1ccc(C(F)(F)F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 4/20 0.37
IDO1 P14902 2/20 0.36
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
AMY1A P0DUB6 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
APP P05067 1/20 0.33
KCNH2 Q12809 2/20 0.32
CCNE2 O96020 1/20 0.32
CCNA2 P20248 1/20 0.32
CCNE1 P24864 1/20 0.32
CDK2 P24941 1/20 0.32
CCNA1 P78396 1/20 0.32
KIF11 P52732 1/20 0.32
BACE1 P56817 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28093529 1.00 PDE2A (0.37) PDE2AIDO1KDM4EGAAAMY1A
SCHEMBL28094043 0.88 BACE1 (0.39) PDE2AIDO1KDM4EGAAAPP
SCHEMBL28094044 0.88 BACE1 (0.39) PDE2AIDO1KDM4EGAAAPP
SCHEMBL28099631 0.82 GRIN2D (0.47) KDM4EAMY1ACYP1A1CYP1B1BACE1
SCHEMBL30772064 0.79 AMY1A (0.35) KDM4EGAAAMY1A
SCHEMBL17713049 0.75 IDO1 (0.41) PDE2AIDO1KDM4EGAACYP1A1
SCHEMBL26946914 0.75 LMNA (0.50) KDM4EGAA
SCHEMBL17713048 0.75 IDO1 (0.41) PDE2AIDO1KDM4EGAACYP1A1
SCHEMBL13548653 0.75 PDE2A (0.42) PDE2AIDO1KDM4EGAACYP1A1
SCHEMBL31136730 0.74 PDE2A (0.39) PDE2AIDO1KDM4EGAACYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106478497-A Aryl amine derivatives as TTX S blocker 拉夸里亚创药株式会社 2017-03-08 CN disclosed
CN-103958506-B 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH 诺华股份有限公司 2017-02-22 CN disclosed
CN-103249721-B Arylamine Derivatives as TTX-S Blockers 拉夸里亚创药株式会社 2016-10-12 CN disclosed